Literature DB >> 19434384

Significant improvement in the quality of life in women treated with a novel disposable intravaginal device for stress urinary incontinence.

Elan Ziv1, Stuart L Stanton, Joseph Abarbanel.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of the study was to assess the quality of life (QoL) in women with stress urinary incontinence (SUI) while using a novel disposable intravaginal device.
METHODS: Fifty women with severe SUI who completed a 7-day control period followed by a 28-day device usage period underwent QoL assessments based on two validated questionnaires, the Incontinence Impact Questionnaire (IIQ-7) and the Urogenital Distress Inventory (UDI-6).
RESULTS: Mean total score for the IIQ-7 decreased from 41.8 +/- 24.1 to 4.4 +/- 8.7 at the pre- and poststudy visits, respectively (P < 0.001). The mean total score for the UDI-6 decreased from 48.2 +/- 16.1 to 11.5 +/- 11.9 at the pre- and poststudy visits, respectively (P < 0.001). Statistically significant decreases in most subscale scores were observed by the end of the study for both questionnaires (all P values <0.001).
CONCLUSION: The novel disposable intravaginal device significantly improved QoL in women with SUI.

Entities:  

Mesh:

Year:  2009        PMID: 19434384     DOI: 10.1007/s00192-009-0824-y

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  15 in total

Review 1.  Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications.

Authors:  P M Latthe; R Foon; P Toozs-Hobson
Journal:  BJOG       Date:  2007-03-16       Impact factor: 6.531

2.  Update: the "Contiform" intravaginal device in four sizes for the treatment of stress incontinence.

Authors:  W A Allen; H Leek; A Izurieta; K H Moore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

3.  Efficacy and safety of a novel disposable intravaginal device for treating stress urinary incontinence.

Authors:  Elan Ziv; Stuart L Stanton; Joseph Abarbanel
Journal:  Am J Obstet Gynecol       Date:  2008-04-02       Impact factor: 8.661

4.  The quality of life in women with urinary incontinence as measured by the sickness impact profile.

Authors:  S Hunskaar; A Vinsnes
Journal:  J Am Geriatr Soc       Date:  1991-04       Impact factor: 5.562

5.  A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests.

Authors:  H Sandvik; A Seim; A Vanvik; S Hunskaar
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

6.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

7.  The Contiform incontinence device - efficacy and patient acceptability.

Authors:  A R Morris; K H Moore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-18

8.  Effectiveness of a new self-positioning pessary for the management of urinary incontinence in women.

Authors:  Scott A Farrell; Sandra Baydock; Baharak Amir; Cora Fanning
Journal:  Am J Obstet Gynecol       Date:  2007-05       Impact factor: 8.661

9.  Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group.

Authors:  S A Shumaker; J F Wyman; J S Uebersax; D McClish; J A Fantl
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

10.  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

Authors:  J S Uebersax; J F Wyman; S A Shumaker; D K McClish; J A Fantl
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.